Activation of Autophagy and Suppression of Apoptosis by Dapagliflozin Attenuates Inflammatory Bowel Disease
Condition: Inflammatory Bowel Diseases Interventions: Drug: Mesalamine; Drug: Dapagliflozin 10mg Tab Sponsor: Mostafa Bahaa Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 10, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.
Condition: Nephrotic Syndrome Interventions: Drug: Dapagliflozin and Standard therapy (ACEI or ARB).; Drug: Standard Therapy (ACEI or ARB). Sponsor: Ain Shams University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
A Study to Evaluate the Efficacy and Safety of Dapagliflozin in Patient With Type 2 Diabetes Mellitus and Hypertension
Conditions: Diabetes Mellitus; Hypertension Intervention: Sponsor: Boryung Pharmaceutical Co., Ltd Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 1, 2023 Category: Research Source Type: clinical trials
